Target intelligence / Profile preview

Undecaprenyl-diphosphate phosphatase (UppP)

Target
UppP
Molecular classification
Enzyme, Hydrolase, Phosphatase
01

Overview

Undecaprenyl-diphosphate phosphatase (UppP), also known as BacA, is an essential integral membrane enzyme in bacteria that catalyzes the dephosphorylation of undecaprenyl diphosphate (UPP) to undecaprenyl phosphate (UP) [1][2]. This enzymatic step is a critical bottleneck in the peptidoglycan biosynthesis pathway, as UP serves as the vital C55-lipid carrier that transports sugar-peptide precursors across the cytoplasmic membrane to the growing cell wall [3]. By recycling UPP—which is generated both de novo and as a byproduct of peptidoglycan polymerization—UppP maintains the steady-state levels of UP necessary for continuous cell wall assembly [2][4]. Inhibition of this process leads to the depletion of the lipid carrier pool, resulting in the cessation of cell wall synthesis and subsequent bacterial cell death [3]. While the classic antibiotic bacitracin targets this pathway by sequestering the UPP substrate, UppP itself is a primary target for developing new antimicrobial strategies to combat multi-drug resistant pathogens [1][4]. Because the peptidoglycan synthesis machinery is unique to bacteria, UppP offers a high degree of selectivity with minimal potential for off-target effects in human hosts [2].

Other names
BacAUndecaprenyl pyrophosphate phosphataseC55-isoprenyl pyrophosphate phosphataseUPP phosphataseUndecaprenyl-diphosphatase
02

Mechanism of action

Inhibition of undecaprenyl phosphate recycling by preventing the dephosphorylation of undecaprenyl diphosphate, thereby halting peptidoglycan precursor transport and cell wall synthesis.

03

Biological functions

Peptidoglycan biosynthesisCell wall assemblyLipid carrier recyclingIsoprenoid metabolism
04

Disease associations

Infection
05

Safety considerations

Development of bacterial resistance (e.g., via overexpression of alternative phosphatases like PgpB or LpxT)Limited penetration in Gram-negative outer membranes for some inhibitors
06

Interacting drugs

Bacitracin
07

Biomarkers

Bacterial growth inhibitionAccumulation of undecaprenyl diphosphatePeptidoglycan synthesis rate

Beyond the preview

Go deeper on Undecaprenyl-diphosphate phosphatase (UppP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Undecaprenyl-diphosphate phosphatase (UppP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call